BioCrossroads Names New Venture Competition Finalists
BioCrossroads will name the winner of this year's competition in October.
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowIndiana’s life sciences initiative has named the finalists for its sixth annual New Venture Competition. BioCrossroads says the five finalists will compete for a total of $50,000 in cash prizes next week during the 2017 Indiana Life Sciences Summit.
The winner of the competition will receive a cash prize of $25,000 as well as access to the Indiana Seed Fund staff and the fund’s network of business planning and early-stage strategic support resources. Second and third place winners will receive $15,000 and $10,000, respectively.
The competition was open to health information technology companies as well as companies in other life sciences disciplines, including biotechnology, pharmaceutical, medical device, diagnostic and ag-biotech. The five finalists include:
- Indiana Lysis Technologies: A product-based discovery company with core-competency in nanoparticle drug delivery seeking to initially commercialize a patent-pending clot dissolving technology.
- Inscope Medical Solutions: A medical device company focused on developing low cost, disposable, connected medical devices.
- LIGHTSPRITE: Specializing in design, manufacturing and sales of nanoparticle characterization systems using Light Transmission Spectroscopy (LTS).
- LoDos Theranostics: A development stage oncology company developing a “first in class” UVA therapy for deep tumors.
- The Bee Corp: A company whose mission is to mitigate beehive loss through data analytics and software development.
The winners will be announced at the Indiana Life Sciences Summit Networking Reception on October 9 in Indianapolis.
BioCrossroads says, since 2012, the New Venture Competition has awarded more than $300,000 to 20 startup companies, which have since secured more than $26.5 million in follow-up funding.